Good User Reputation for Glycitein - Isoastragaloside I – Yongjian
Good User Reputation for Glycitein - Isoastragaloside I – Yongjian Detail:
Application Of Isoastragaloside I
Astragaloside is a natural compound of astragaloside, which can improve the activity of astragaloside I.
Biological Activity of Isoastragaloside I
Description: isoastragaloside I is a natural compound of Astragalus membranaceus, which has the activity of increasing the amount of adiponectin.
Related categories: signal path > > other > > other
Research field > > metabolic diseases
Natural Products > > terpenoids and glycosides
References: [1] Xu A, et al. Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice. Endocrinology. 2009 Feb; 150(2):625-33.
Physicochemical Properties Of Isoastragaloside I
Density: 1.4 ± 0.1 g / cm3
Boiling point: 920.6 ± 65.0 ° C at 760 mmHg
Molecular Formula: C45H72O16
Molecular Weight: 869.044
Flash Point: 264.7 ± 27.8 ° C
Exact mass: 868.482056
PSA:240.36000
LogP:2.03
Steam pressure: 0.0 ± 0.6 mmHg at 25 ° C
Refractive index: 1.596
English Alias Isoastragaloside I
β-D-Glucopyranoside, (3β,6α,9β,16β,20R,24S)-3-[(2,4-di-O-acetyl-β-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl
Isoastragaloside-I
(3β,6α,9β,16β,20R,24S)-3-[(2,4-Di-O-acetyl-β-D-xylopyranosyl)oxy]-16,25-dihydroxy-20,24-epoxy-9,19-cyclolanostan-6-yl β-D-glucopyranoside
Jiangsu Yongjian Pharmaceutical Technology Co., Ltd
Jiangsu Yongjian Pharmaceutical Technology Co., Ltd., established in March 2012, is a high-tech enterprise integrating R & D, production and sales. It is mainly engaged in the production, customization and production process development of active components of natural products, traditional Chinese medicine reference materials and drug impurities. The company is located in China Pharmaceutical City, Taizhou City, Jiangsu Province, including a 5000 square meter production base and a 2000 square meter R & D base. It mainly serves major scientific research institutes, universities and decoction piece production enterprises across the country.
So far, we have developed more than 1500 kinds of natural compound reagents, and compared and calibrated more than 300 kinds of reference materials, which can fully meet the daily inspection needs of major scientific research institutes, university laboratories and decoction pieces production enterprises.
Based on the principle of good faith, the company hopes to sincerely cooperate with our customers. Our aim is to serve the modernization of traditional Chinese medicine.
Advantageous business scope of the company:
1. R & D, production and sales of chemical reference materials of traditional Chinese medicine;
2. Customized traditional Chinese medicine monomer compounds according to customer characteristics
3. Research on quality standard and process development of traditional Chinese medicine (plant) extract
4. Technology cooperation, transfer and new drug research and development.
Product detail pictures:
Related Product Guide:
We take pleasure in an exceptionally excellent status between our buyers for our superb merchandise good quality, aggressive price tag and the greatest support for Good User Reputation for Glycitein - Isoastragaloside I – Yongjian , The product will supply to all over the world, such as: America, Turkey, San Diego, We honor ourselves as a company that comprises of a strong team of professionals who are innovative and well experienced in the international trading, business development and product advancement. Moreover, the company stays unique among its competitors due to its superior standard of quality in production, and its efficiency and flexibility in business support.
By April from Ireland - 2018.02.04 14:13
The sales manager has a good English level and skilled professional knowledge, we have a good communication. He is a warm and cheerful man, we have a pleasant cooperation and we became very good friends in private.
By Myra from Mauritius - 2017.09.09 10:18
